Positive clinical and biochemical responses to anakinra in a 3-yr-old patient with cryopyrin-associated periodic syndrome (CAPS) [4]

Rheumatology

Volumn 44, Issue 8, 2005, Pages 1072-1073

  Ramos, E ^b   Arostegui J I ^a   Campuzano, S ^b   Rius, J ^a   Bousono C ^b   Yague J ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CORTICOSTEROID; CRYOPYRIN; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; ANTIRHEUMATIC AGENT; CARRIER PROTEIN; CIAS1 PROTEIN, HUMAN; IL1RN PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SIALOGLYCOPROTEIN;

CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CRYOPYRIN ASSOCIATED PERIODIC SYNDROME; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; HETEROZYGOSITY; HOSPITALIZATION; HUMAN; INFLAMMATORY DISEASE; LETTER; MALE; MUTATIONAL ANALYSIS; OUTPATIENT CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; SIDE EFFECT; SYMPTOMATOLOGY; TREATMENT FAILURE; DRUG ANTAGONISM; FAMILIAL MEDITERRANEAN FEVER; GENETICS; MUTATION;

ANTIRHEUMATIC AGENTS; CARRIER PROTEINS; CHILD, PRESCHOOL; FAMILIAL MEDITERRANEAN FEVER; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MUTATION; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS;

EID: 24944528385     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keh652     Document Type: Letter

References (9)

1. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Koloder RD. Mutations of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001;29:301-5.
2. Feldmann J, Prieur AM, Quartier P et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 2002;71:198-203.
3. Martinon F, Tschopp J. Inflammatory caspases: Linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004;117:561-74.
4. Arostegui JI, Aldea A, Modesto C et al. Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene. Arthritis Rheum 2004;50:4045-50.
5. Hawkins PN, Lachmann HJ, McDermott MF. Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med 2003;348:2583-4.
6. Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 2004;50:607-12.
7. Hawkins PN, Bybee A, Aganna E, McDermott MF. Response to anakinra in a de novo case of neonatal-onset multisystem inflammatory disease. Arthritis Rheum 2004;50:2708-9.
8. Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 2001; 358:24-9.
9. Dierselhuis MP, Frenkel J, Wulffraat NM, Boelens JJ. Anakinra for flares of pyogenic arthritis in PAPA syndrome. Rheumatology 2005;44:406-8.